These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22948941)

  • 1. Analysis of endogenous Oct4 activation during induced pluripotent stem cell reprogramming using an inducible Oct4 lineage label.
    Greder LV; Gupta S; Li S; Abedin MJ; Sajini A; Segal Y; Slack JM; Dutton JR
    Stem Cells; 2012 Nov; 30(11):2596-601. PubMed ID: 22948941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
    Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
    Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
    Yuan X; Wan H; Zhao X; Zhu S; Zhou Q; Ding S
    Stem Cells; 2011 Mar; 29(3):549-53. PubMed ID: 21425417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
    Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
    Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNAs sustain high expression levels of exogenous octamer-binding protein 4 by sponging regulatory microRNAs during cellular reprogramming.
    Zhang X; Zhang J; Zheng K; Zhang H; Pei X; Yin Z; Wen D; Kong Q
    J Biol Chem; 2019 Nov; 294(47):17863-17874. PubMed ID: 31624145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic tool for fate mapping of Oct4 (Pou5f1)-expressing cells and their progeny past the pluripotency stage.
    Kuzmin AA; Ermakova VV; Sinenko SA; Ponomartsev SV; Starkova TY; Skvortsova EV; Cherepanova O; Tomilin AN
    Stem Cell Res Ther; 2019 Dec; 10(1):391. PubMed ID: 31843009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
    Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds.
    Shi Y; Desponts C; Do JT; Hahm HS; Schöler HR; Ding S
    Cell Stem Cell; 2008 Nov; 3(5):568-74. PubMed ID: 18983970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.
    Watanabe S; Hirai H; Asakura Y; Tastad C; Verma M; Keller C; Dutton JR; Asakura A
    Stem Cells; 2011 Mar; 29(3):505-16. PubMed ID: 21425413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
    Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
    Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
    Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
    Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.